Achieve Life Sciences Inc. - Multiplikator nilai perusahaan marang pendapatan ACHV

Simbol resmi perusahaan Achieve Life Sciences, Inc. (ACHV)

The enterprise value-to-revenue dynamics of Achieve Life Sciences (ACHV) reflect market expectations for the developer of nicotine addiction treatments targeting a broad range of smokers. The safe plant alkaloid cytisiniclinal provides the company with unique pricing power. Meanwhile, the value of 0.00 captures the metric level amid a reliance on external laboratories, with whom management is optimizing interactions to accelerate drug registration.

Achieve Life Sciences, Inc. (ACHV) - Multiplikator EV/Sales saka 23.11.2025 nganti 10.11.2026

ACHV (Achieve Life Sciences, Inc): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:ACHV (Achieve Life Sciences)
Sampel barang Achieve Life Sciences Inc.

Fundamental asset screening begins with identifying undervalued companies through multiple analysis. The EV/Sales ratio reflects the total value of the business, including debt minus cash, per unit of revenue. A decline in this metric may signal a market discount. For Achieve Life Sciences (ACHV), valuation is critically tied to the commercial success of citizinineclin. The final enterprise value will depend on FDA approval and the acquisition of a strategic partner.